BRIEF published on 09/03/2025 at 16:57, 3 months 1 day ago Ernst Russ AG Shows Resilient Performance Amid Challenges Market Strategy Fleet Management Ernst Russ AG Charter Rates H1 2025 Results
PRESS RELEASE published on 09/03/2025 at 16:52, 3 months 1 day ago Original-Research: Ernst Russ AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy Ernst Russ AG receives positive review for solid H1 2025 results and strong charter rates. Buy recommendation with EUR 10.00 TP upheld by analysts Buy Recommendation Ernst Russ AG Charter Rates H1 2025 Results EUR 10.00 TP
BRIEF published on 08/28/2025 at 07:37, 3 months 7 days ago Ernst Russ AG Reports Financial Growth Amidst Challenges in H1 2025 Leadership Changes Geopolitical Challenges Capital Market Strategy Revenue And EBIT Financial Results 2025
PRESS RELEASE published on 08/28/2025 at 07:32, 3 months 7 days ago Ernst Russ Announces Financial Results for the First Half of 2025 Ernst Russ AG announces strong financial results for the first half of 2025, with focused growth strategies. Targeted portfolio optimization and vessel sales drove earnings increase Financial Results Ernst Russ AG Growth Strategies First Half 2025 Vessel Sales
BRIEF published on 06/05/2025 at 13:39, 5 months 29 days ago Ernst Russ AG: Solid Performance in Volatile Markets Investment Rating EBIT Growth Ernst Russ AG Shipping Markets Charter Rates
PRESS RELEASE published on 06/05/2025 at 13:34, 5 months 29 days ago Original-Research: Ernst Russ AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy Ernst Russ AG shows solid performance in volatile shipping markets, with a focus on fleet reduction and future growth. Strong balance sheet and earnings outlook. Full research available for download Balance Sheet Ernst Russ AG Earnings Outlook Shipping Markets Fleet Reduction
BRIEF published on 05/26/2025 at 08:09, 6 months 9 days ago Management Changes and Strategic Developments at Ernst Russ AG Executive Board Management Changes Shipping Industry Ernst Russ AG 2025 AGM
PRESS RELEASE published on 05/26/2025 at 08:04, 6 months 9 days ago Change in management and clear majorities at the 2025 Annual General Meeting of Ernst Russ AG Ernst Russ AG announces management changes and successful AGM outcomes at the 2025 Annual General Meeting in Hamburg, with new Executive Board member and co-CEOs appointed Annual General Meeting Executive Board Co-CEOs Management Changes Ernst Russ AG
BRIEF published on 05/21/2025 at 07:31, 6 months 14 days ago Ernst Russ AG Reports Stable Q1 2025 Amid Global Challenges Financial Results Ernst Russ AG Stable Performance Q1 2025 Fleet Strategy
PRESS RELEASE published on 05/21/2025 at 07:26, 6 months 14 days ago Ernst Russ AG in Q1 2025: Positive business performance despite global uncertainties Ernst Russ AG reports positive Q1 2025 performance despite global uncertainties. Focus on fleet strategy and solid key figures. Future outlook remains optimistic Business Performance Ernst Russ AG Q1 2025 Global Uncertainties Fleet Strategy
Published on 12/05/2025 at 02:35, 3 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 53 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 2 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
